Discovery Life Sciences, LLC was awarded a $25,000 firm fixed price purchase order by the National Cancer Institute, a component of the Department of Health and Human Services' National Institutes of Health, to provide proteomics project management and setup services. The contract has a period of performance from August 11, 2023 through October 11, 2023, with all work to be conducted by Discovery Life Sciences at its Bethesda, Maryland location. As the prime contractor on this small purchase, Discovery Life Sciences will deliver proteomics project setup and coordination to support the National Cancer Institute's biomedical research initiatives. No subcontractors or set aside designations were identified in the award information.
Generated 12/19/23, 9:22 PM